Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(67%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
2
33%
Ph not_applicable
1
17%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Completed(1)

Detailed Status

Recruiting3
Not yet recruiting1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 32 (33.3%)
N/A1 (16.7%)

Trials by Status

not_yet_recruiting117%
completed117%
recruiting350%
active_not_recruiting117%

Recent Activity

4 active trials
Showing 5 of 6
completedphase_2

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06124807
recruitingnot_applicable

ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management

NCT07517042
active_not_recruitingphase_2

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

NCT06817356
recruitingphase_3

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

NCT07083154
not_yet_recruitingphase_3

A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

NCT07417306
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06124807Phase 2

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

Completed
NCT07517042Not Applicable

ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management

Recruiting
NCT06817356Phase 2

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Active Not Recruiting
NCT07083154Phase 3

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Recruiting
NCT07417306Phase 3

A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Not Yet Recruiting
NCT06519656Phase 1

Efficacy of Mazdutide for Treating PCOS

Recruiting

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6